Updated Jul 16, 2026
Wilkinson Peter J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $674K.
Peter J. Wilkinson is the Senior Vice President and Chief Accounting Officer at Labcorp Holdings Inc. He has been involved in the financial management of the company, contributing to its operations as one of the largest independent clinical laboratories in the U.S.
| Role | SVP, Chief Accounting Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-30 | LH | LABCORP HOLDINGS INC. | S — Open-market sale [10b5-1] | 1.6K | $267.05 | $436K |
| 2026-03-30 | LH | LABCORP HOLDINGS INC. | F — Tax withholding / forfeiture [10b5-1] | 755 | $268.38 | $203K |
| 2026-03-30 | LH | LABCORP HOLDINGS INC. | A — Grant or award [10b5-1] | 2.4K | $0.00 | |
| 2026-02-23 | LH | LABCORP HOLDINGS INC. | S — Open-market sale [10b5-1] | 666 | $277.94 | $185K |
| 2026-02-13 | LH | LABCORP HOLDINGS INC. | F — Tax withholding / forfeiture | 46 | $289.89 | $13K |
| 2026-02-13 | LH | LABCORP HOLDINGS INC. | M — Option exercise | 160 | — | |
| 2026-02-13 | LH | LABCORP HOLDINGS INC. | F — Tax withholding / forfeiture | 160 | $289.89 | $46K |
| 2026-02-13 | LH | LABCORP HOLDINGS INC. | M — Option exercise | 536 | — | |
| 2026-02-10 | LH | LABCORP HOLDINGS INC. | F — Tax withholding / forfeiture | 46 | $274.01 | $13K |
| 2026-02-10 | LH | LABCORP HOLDINGS INC. | M — Option exercise | 134 | — | |
| 2026-02-10 | LH | LABCORP HOLDINGS INC. | F — Tax withholding / forfeiture | 45 | $277.20 | $12K |
| 2026-02-10 | LH | LABCORP HOLDINGS INC. | M — Option exercise | 133 | — | |
| 2025-07-29 | LH | LABCORP HOLDINGS INC. | S — Open-market sale | 100 | $261.04 | $26K |
| 2025-07-29 | LH | LABCORP HOLDINGS INC. | S — Open-market sale | 102 | $261.01 | $27K |
Peter J. Wilkinson is the Senior Vice President and Chief Accounting Officer at Labcorp Holdings Inc. He has been involved in the financial management of the company, contributing to its operations as one of the largest independent clinical laboratories in the U.S.…
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($674K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Wilkinson Peter J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.